Brolucizumab—another anti-VEGF or beyond

Ashish Sharma; Nikulaa Parachuri; Nilesh Kumar; Rohini Sharma; Francesco Bandello; Baruch D. Kuppermann; Anat Loewenstein

doi:10.1038/s41433-020-0888-y

Brolucizumab—another anti-VEGF or beyond

Ashish Sharma^*, Nikulaa Parachuri, Nilesh Kumar, Rohini Sharma, Francesco Bandello, Baruch D. Kuppermann, Anat Loewenstein

^*Corresponding author for this work

Ophthalmology

Research output: Contribution to journal › Comment/debate

10 Scopus citations

Original language	English
Pages (from-to)	1499-1500
Number of pages	2
Journal	Eye (Basingstoke)
Volume	34
Issue number	9
DOIs	https://doi.org/10.1038/s41433-020-0888-y
State	Published - 1 Sep 2020

Access to Document

10.1038/s41433-020-0888-y

Cite this

@article{e30a006fdd95433d82d1a589e1447e07,

title = "Brolucizumab—another anti-VEGF or beyond",

author = "Ashish Sharma and Nikulaa Parachuri and Nilesh Kumar and Rohini Sharma and Francesco Bandello and Kuppermann, {Baruch D.} and Anat Loewenstein",

year = "2020",

month = sep,

day = "1",

doi = "10.1038/s41433-020-0888-y",

language = "אנגלית",

volume = "34",

pages = "1499--1500",

journal = "Eye (Basingstoke)",

issn = "0950-222X",

publisher = "Springer Nature",

number = "9",

}

TY - JOUR

T1 - Brolucizumab—another anti-VEGF or beyond

AU - Sharma, Ashish

AU - Parachuri, Nikulaa

AU - Kumar, Nilesh

AU - Sharma, Rohini

AU - Bandello, Francesco

AU - Kuppermann, Baruch D.

AU - Loewenstein, Anat

PY - 2020/9/1

Y1 - 2020/9/1

UR - http://www.scopus.com/inward/record.url?scp=85084062468&partnerID=8YFLogxK

U2 - 10.1038/s41433-020-0888-y

DO - 10.1038/s41433-020-0888-y

M3 - ???researchoutput.researchoutputtypes.contributiontojournal.comment???

C2 - 32317791

AN - SCOPUS:85084062468

SN - 0950-222X

VL - 34

SP - 1499

EP - 1500

JO - Eye (Basingstoke)

JF - Eye (Basingstoke)

IS - 9

ER -

Brolucizumab—another anti-VEGF or beyond

Access to Document

Other files and links

Cite this